179 related articles for article (PubMed ID: 11157725)
21. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
[TBL] [Abstract][Full Text] [Related]
22. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.
Ploplis VA; Cornelissen I; Sandoval-Cooper MJ; Weeks L; Noria FA; Castellino FJ
Am J Pathol; 2001 Jan; 158(1):107-17. PubMed ID: 11141484
[TBL] [Abstract][Full Text] [Related]
23. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.
Hill SA; Shaughnessy SG; Joshua P; Ribau J; Austin RC; Podor TJ
Blood; 1996 Jun; 87(12):5061-73. PubMed ID: 8652819
[TBL] [Abstract][Full Text] [Related]
24. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice.
Farrehi PM; Ozaki CK; Carmeliet P; Fay WP
Circulation; 1998 Mar; 97(10):1002-8. PubMed ID: 9529269
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
26. Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1).
Lijnen HR; Van Hoef B; Umans K; Collen D
J Thromb Haemost; 2004 Jan; 2(1):16-22. PubMed ID: 14717961
[TBL] [Abstract][Full Text] [Related]
27. Vitronectin Regulates the Fibrinolytic System during the Repair of Cerebral Cortex in Stab-Wounded Mice.
Hashimoto K; Ikeda N; Nakashima M; Ikeshima-Kataoka H; Miyamoto Y
J Neurotrauma; 2017 Nov; 34(22):3183-3191. PubMed ID: 28683586
[TBL] [Abstract][Full Text] [Related]
28. Intra- and extracellular plasminogen activator inhibitor-1 regulate effect of vitronectin against radiation-induced endothelial cell death.
Hazawa M; Yasuda T; Saotome-Nakamura A; Tomiyama K; Obara C; Goto T; Tajima K
Vascul Pharmacol; 2016 Dec; 87():150-158. PubMed ID: 27650166
[TBL] [Abstract][Full Text] [Related]
29. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
[TBL] [Abstract][Full Text] [Related]
31. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury.
Sawa H; Sobel BE; Fujii S
Circ Res; 1993 Oct; 73(4):671-80. PubMed ID: 7690310
[TBL] [Abstract][Full Text] [Related]
32. Abrogation of plasminogen activator inhibitor-1-vitronectin interaction ameliorates acute kidney injury in murine endotoxemia.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
PLoS One; 2015; 10(3):e0120728. PubMed ID: 25799354
[TBL] [Abstract][Full Text] [Related]
33. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.
Carmeliet P; Moons L; Lijnen R; Janssens S; Lupu F; Collen D; Gerard RD
Circulation; 1997 Nov; 96(9):3180-91. PubMed ID: 9386191
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
36. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
[TBL] [Abstract][Full Text] [Related]
37. Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis.
Praus M; Collen D; Gerard RD
Int J Cancer; 2002 Dec; 102(6):584-91. PubMed ID: 12447999
[TBL] [Abstract][Full Text] [Related]
38. Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes.
Stoop AA; Lupu F; Pannekoek H
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1143-9. PubMed ID: 10764685
[TBL] [Abstract][Full Text] [Related]
39. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function.
Chavakis T; Pixley RA; Isordia-Salas I; Colman RW; Preissner KT
J Biol Chem; 2002 Sep; 277(36):32677-82. PubMed ID: 12082110
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats.
Hasenstab D; Forough R; Clowes AW
Circ Res; 1997 Apr; 80(4):490-6. PubMed ID: 9118479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
